CLPCX
Price
$13.54
Change
-$0.31 (-2.24%)
Updated
Dec 12 closing price
Net Assets
15.97M
JHQPX
Price
$35.34
Change
-$0.25 (-0.70%)
Updated
Dec 12 closing price
Net Assets
21.34B
Interact to see
Advertisement

CLPCX vs JHQPX

Header iconCLPCX vs JHQPX Comparison
Open Charts CLPCX vs JHQPXBanner chart's image
Catalyst Nasdaq-100 Hedged Equity C
Price$13.54
Change-$0.31 (-2.24%)
VolumeN/A
Net Assets15.97M
JPMorgan Hedged Equity R5
Price$35.34
Change-$0.25 (-0.70%)
VolumeN/A
Net Assets21.34B
CLPCX vs JHQPX Comparison Chart in %
View a ticker or compare two or three
VS
CLPCX vs. JHQPX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPCX is a StrongBuy and JHQPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JHQPX has more cash in the bank: 21.3B vs. CLPCX (16M). JHQPX pays higher dividends than CLPCX: JHQPX (0.85) vs CLPCX (0.00). CLPCX was incepted earlier than JHQPX: CLPCX (12 years) vs JHQPX (12 years). CLPCX (3.37) is less costly to investors than JHQPX (0.43). CLPCX is a more actively managed with annual turnover of: 31.00 vs. JHQPX (20.00). JHQPX has a lower initial minimum investment than CLPCX: JHQPX (0) vs CLPCX (2500). CLPCX annual gain was more profitable for investors over the last year : 11.96 vs. JHQPX (5.37). JHQPX return over 5 years is better than : 54.97 vs. CLPCX (33.05).
CLPCXJHQPXCLPCX / JHQPX
Total Expense Ratio2.580.43600%
Annual Report Gross Expense Ratio3.370.43784%
Fund Existence12 years12 years-
Gain YTD15.6097.928197%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets16M21.3B0%
Annual Yield % from dividends0.000.85-
Returns for 1 year11.965.37223%
Returns for 3 years59.2049.10121%
Returns for 5 years33.0554.9760%
Returns for 10 years33.69144.5923%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCRX25.730.55
+2.18%
Pacira BioSciences
MMSI86.531.11
+1.30%
Merit Medical Systems
CVNA472.735.06
+1.08%
Carvana Co
DAAQ10.170.01
+0.10%
Digital Asset Acquisition Corp
BOLD1.15-0.01
-0.86%
Boundless Bio